Pharmaceutical Technology, March 2025

Industry 4.0 is driving adoption in the pharma industry for smart equipment and tools that will advance manufacturing.

The ‘full tolerance coverage method’ is introduced as a coverage estimation approach for assessing the uniformity of dosage units from large sample sizes, ensuring that no dosage unit exceeds the specification range.

Exosomes, polymeric nanoparticles, and DNA nanostructures offer many potential advantages.

Continuous manufacturing offers advantages in both biotherapeutic and API manufacturing but still poses challenges.

Being fully versed on the ins and outs of design quality can improve the project design phase life cycle.

More and more contract manufacturers have been looking not at what the state of the supply chain is right now, but what it may be in the next three to five years.

The Biotech and Biomanufacturing Hub will help European companies access funding, navigate regulations, and speed up market access.

Compliance and competitiveness are key factors in aseptic processing, says Siegfried Schmitt, PhD, vice president, Technical at Parexel.

Artificial intelligence, among other technological advances, is pushing innovation boundaries.